Thyrocare Technologies Ltd - 539871 - Updates on Open Offer
JM Financial Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (as amended) to the Public Shareholders of Thyrocare Technologies Ltd ("Target Company"). Thyrocare Technologies Ltd - 539871 - Updates on Open Offer
JM Financial Ltd ("Manager to the Offer") vide its letter dated July 09, 2021 has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Thyrocare Technologies Ltd ("Target Company"). Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd
PharmEasy founder Siddharth Shah buys apartment in Mumbai for Rs 40 crore
Online pharmacy chain PharmEasy had recently acquired Thyrocare. The apartment is located off Carter Road at Khar West in Mumbai. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30, read with Schedule III Part A Para A and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith the copies of newspaper advertisement of unaudited financial results for the Quarter ended 30th June 2021, published in Free Press Journal (English) and Pudhari (Marathi), . Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation
Forwarding copy of Presentation on Quarterly Results of our company for the quarter ended 30-06-2021. Thyrocare Technologies Ltd - 539871 - Outcome Of Board Meeting Held On 12-08-2021
This is to inform you that the Board of Directors of the Company, at their meeting held today, approved the unaudited Financial Results (Stand-alone and Consolidated) for the quarter ended June 30, 2021. Thyrocare Technologies Ltd - 539871 - Board Meeting Outcome for Outcome Of Board Meeting Held On 12-08-2021
This is to inform you that the Board of Directors of the Company, at their meeting held today, approved the unaudited Financial Results (Stand-alone and Consolidated) for the quarter ended June 30, 2021. Thyrocare Technologies Ltd - 539871 - Updats on Open Offer
JM Financial Ltd ("Manager to the Offer") has submitted to BSE a copy of Advertisement under Regulation 18(7) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended and Corrigendum to the Detailed Public Statement for the attention of the Public Shareholders ofThyrocare Technologies Ltd ("Target Company").
